Third universal definition of myocardial infarction.

AUTHORS/TASK FORCE MEMBERS CHAIRPERSONS Kristian Thygesen (Denmark),* Joseph S. Alpert (USA),* Harvey D. White (New Zealand),* Biomarker Subcommittee: Allan S. Jaffe (USA), Hugo A. Katus (Germany), Fred S. Apple (USA), Bertil Lindahl (Sweden), David A. Morrow (USA), ECG Subcommittee: Bernard R. Chaitman (USA), Peter M. Clemmensen (Denmark), Per Johanson (Sweden), Hanoch Hod (Israel), Imaging Subcommittee: Richard Underwood (UK), Jeroen J. Bax (The Netherlands), Robert O. Bonow (USA), Fausto Pinto (Portugal), Raymond J. Gibbons (USA), Classification Subcommittee: Keith A. Fox (UK), Dan Atar (Norway), L. Kristin Newby (USA), Marcello Galvani (Italy), Christian W. Hamm (Germany), Intervention Subcommittee: Barry F. Uretsky (USA), Ph. Gabriel Steg (France), William Wijns (Belgium), Jean-Pierre Bassand (France), Phillippe Menasché (France), Jan Ravkilde (Denmark), Trials & Registries Subcommittee: E. Magnus Ohman (USA), Elliott M. Antman (USA), Lars C. Wallentin (Sweden), Paul W. Armstrong (Canada), Maarten L. Simoons (The Netherlands), Heart Failure Subcommittee: James L. Januzzi (USA), Markku S. Nieminen (Finland), Mihai Gheorghiade (USA), Gerasimos Filippatos (Greece), Epidemiology Subcommittee: Russell V. Luepker (USA), Stephen P. Fortmann (USA), Wayne D. Rosamond (USA), Dan Levy (USA), David Wood (UK), Global Perspective Subcommittee: Sidney C. Smith (USA), Dayi Hu (China), José-Luis Lopez-Sendon (Spain), Rose Marie Robertson (USA), Douglas Weaver (USA), Michal Tendera (Poland), Alfred A. Bove (USA), Alexander N. Parkhomenko (Ukraine), Elena J. Vasilieva (Russia), Shanti Mendis (Switzerland)

Douglas Weaver | Jeroen J. Bax | William Wijns | Hugo A Katus | Gerasimos Filippatos | Fausto Pinto | Joseph S Alpert | David A Morrow | Richard Underwood | Paul W Armstrong | Alfred A Bove | Kristian Thygesen | D. Atar | A. Parkhomenko | E. Antman | J. Alpert | G. Filippatos | M. Nieminen | A. Jaffe | R. Gibbons | P. Armstrong | H. White | E. Ohman | Sidney C. Smith | R. Bonow | W. Rosamond | M. Gheorghiade | B. Chaitman | D. Morrow | M. Simoons | J. López-Sendón | H. Hod | R. Luepker | L. Wallentin | D. Levy | B. Lindahl | M. Tendera | K. Thygesen | S. Fortmann | K. Fox | L. Newby | A. Bove | H. Katus | B. Uretsky | P. Steg | F. Pinto | W. Wijns | C. Hamm | M. Galvani | J. Ravkilde | P. Clemmensen | R. Underwood | J. Bassand | S. Mendis | R. Robertson | J. Januzzi | P. Johanson | P. Menasche | D. Wood | D. Hu | D. Weaver | E. Vasilieva | Harvey D White | Robert O Bonow | Elliott M Antman | Sidney C Smith | Raymond J Gibbons | Bertil Lindahl | Maarten L Simoons | Markku S Nieminen | Jeroen J Bax | Christian W Hamm | E Magnus Ohman | James L Januzzi | Russell V Luepker | Rose Marie Robertson | Barry F Uretsky | Michal Tendera | Ph Gabriel Steg | Bernard R Chaitman | Allan S Jaffe | Per Johanson | Dan Atar | Jean-Pierre Bassand | Mihai Gheorghiade | Dayi Hu | Stephen P Fortmann | Hanoch Hod | Peter M Clemmensen | Keith A Fox | L Kristin Newby | Marcello Galvani | Phillippe Menasché | Jan Ravkilde | Lars C Wallentin | Wayne D Rosamond | Dan Levy | David Wood | José-Luis Lopez-Sendon | Alexander N Parkhomenko | Elena J Vasilieva | Shanti Mendis | E. J. Vasilieva

[1]  L. Horan,et al.  Significance of the Diagnostic Q Wave of Myocardial Infarction , 1971, Circulation.

[2]  R. Jennings,et al.  Structural Changes in Myocardium During Acute Ischemia , 1974, Circulation research.

[3]  R. Ideker,et al.  Correlation of Postmortem Anatomic Findings with Electrocardiographic Changes in Patients with Myocardial Infarction: Retrospective Study of Patients with Typical Anterior and Posterior Infarcts , 1977, Circulation.

[4]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[5]  J. López-Sendón,et al.  Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3. , 1985, Journal of the American College of Cardiology.

[6]  L. Fleisher,et al.  Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease? , 1995, Journal of clinical anesthesia.

[7]  M. Josephson,et al.  Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction. , 1998, The American journal of cardiology.

[8]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[9]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[10]  W R Dassen,et al.  Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.

[11]  Mylan C. Cohen,et al.  Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[12]  D Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. , 1999, Journal of the American College of Cardiology.

[13]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[14]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[15]  T. Nageh,et al.  Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures , 2000, Annals of clinical biochemistry.

[16]  Deepak L. Bhatt,et al.  Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. , 2000, Circulation.

[17]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[18]  Ric,et al.  Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block , 1996 .

[19]  P. Macfarlane.  Age, sex, and the ST amplitude in health and disease. , 2001, Journal of electrocardiology.

[20]  N. Moatti,et al.  Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery , 2001, Critical care medicine.

[21]  B. Chaitman,et al.  Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. , 2001, Journal of the American College of Cardiology.

[22]  S. Neubauer,et al.  Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS). , 2002, Circulation.

[23]  E. Topol,et al.  Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. , 2002, Journal of the American College of Cardiology.

[24]  S. Kathiresan,et al.  A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. , 2002, Journal of the American College of Cardiology.

[25]  L. Holmvang,et al.  Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. , 2002, Chest.

[26]  Mark E Josephson,et al.  Use of the electrocardiogram in acute myocardial infarction. , 2003, The New England journal of medicine.

[27]  R. Asinger,et al.  ST-segment elevation in conditions other than acute myocardial infarction. , 2003, The New England journal of medicine.

[28]  P. Doyle,et al.  Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. , 2003, Clinical chemistry.

[29]  C. Gustavsson,et al.  Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury , 2004, Scandinavian cardiovascular journal : SCJ.

[30]  M. Mosseri,et al.  Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. , 2004, Journal of the American College of Cardiology.

[31]  RaffaeleBugiardini,et al.  Endothelial Function Predicts Future Development of Coronary Artery Disease , 2004 .

[32]  J. Guermonprez,et al.  Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. , 2004, Clinical laboratory.

[33]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[34]  M. Burritt,et al.  Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. , 2004, Chest.

[35]  Matthew D. Robson,et al.  Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers , 2004, Circulation.

[36]  C. Sprung,et al.  Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients* , 2005, Critical care medicine.

[37]  S. Petersen,et al.  Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[38]  S. Hill,et al.  Determination of Troponin I Release After CABG Surgery , 2005, Journal of cardiac surgery.

[39]  S. Petersen,et al.  Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.

[40]  J. Herrmann.  Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.

[41]  R. Bugiardini,et al.  Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. , 2006, Archives of internal medicine.

[42]  M. Burritt,et al.  Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. , 2006, European heart journal.

[43]  A. Jaffe,et al.  Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. , 2006, Clinical chemistry.

[44]  A. Jaffe.  Chasing troponin: how low can you go if you can see the rise? , 2006, Journal of the American College of Cardiology.

[45]  N. Nagajothi,et al.  Biomarkers in acute cardiac disease. , 2006, Journal of the American College of Cardiology.

[46]  G. Hillis,et al.  Relationship Between Postoperative Cardiac Troponin I Levels and Outcome of Cardiac Surgery , 2006, Circulation.

[47]  Takahiro Matsumoto.  [Unrecognized myocardial infarction]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[48]  D. Pennell,et al.  The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.

[49]  A. Jaffe,et al.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. , 2007, Clinical chemistry.

[50]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[51]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[52]  J. Alpert,et al.  Diagnostic application of the universal definition of myocardial infarction in the intensive care unit , 2008, Current opinion in critical care.

[53]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[54]  Bekele Afessa,et al.  Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients , 2008, Critical care medicine.

[55]  D. Kraitchman,et al.  Advances in Cardiovascular Imaging Multimodality Cardiovascular Molecular Imaging, Part II , 2008 .

[56]  Karen A. Hartman,et al.  Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[57]  Regina M. Hardison,et al.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[58]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[59]  M. Laakso,et al.  Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. , 2010, European heart journal.

[60]  A. Jaffe,et al.  Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. , 2010, Clinical chemistry.

[61]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[62]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[63]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[64]  H. Taegtmeyer.  Tracing Cardiac Metabolism In Vivo: One Substrate at a Time , 2010, Journal of Nuclear Medicine.

[65]  James McCord,et al.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[66]  A. Beek,et al.  Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction , 2010, Heart.

[67]  F. Apple,et al.  Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. , 2010, Clinical biochemistry.

[68]  G. Stone,et al.  Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention , 2010, Circulation. Cardiovascular interventions.

[69]  M. Cowie,et al.  Cardiac sympathetic imaging with mIBG in heart failure. , 2010, JACC. Cardiovascular imaging.

[70]  A. Lardo,et al.  Assessment of coronary blood flow with computed tomography and magnetic resonance imaging , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[71]  Albert J. Sinusas,et al.  Multimodality Imaging of Myocardial Injury and Remodeling , 2010, Journal of Nuclear Medicine.

[72]  D. Wood,et al.  Mechanisms of Myocardial Infarction in Women Without Angiographically Obstructive Coronary Artery Disease , 2011, Circulation.

[73]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[74]  V. Hasselblad,et al.  Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.

[75]  A. Folsom,et al.  Abstract 13291: Twenty-Two Year Trends in Incidence of Myocardial Infarction, CHD Mortality, and Case-Fatality in Four US Communities, 1987 to 2008 , 2011 .

[76]  B. Gersh,et al.  Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. , 2011, The American journal of cardiology.

[77]  Kari Kuulasmaa,et al.  World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.

[78]  N. Weissman,et al.  A suggested roadmap for cardiovascular ultrasound research for the future. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[79]  D. Jacobs,et al.  The effect of changing diagnostic algorithms on acute myocardial infarction rates. , 2009, Annals of epidemiology.

[80]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[81]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[82]  D. Xavier,et al.  High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. , 2011, Clinical biochemistry.

[83]  D. Newby,et al.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. , 2011, JAMA.

[84]  Stephan Achenbach,et al.  Cardiac imaging after myocardial infarction. , 2011, European heart journal.

[85]  S. Yusuf,et al.  High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. , 2011, Clinical chemistry.

[86]  H. White.  Pathobiology of Troponin Elevations , 2011 .

[87]  G. Lamas,et al.  Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. , 2012, American heart journal.

[88]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[89]  I. Welters.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012 .

[90]  S. Pocock,et al.  Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR) , 2012, Circulation.

[91]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[92]  Fred S Apple,et al.  Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.

[93]  H. White.  The Prequel: Defining Prognostically Important Criteria in the Periprocedural PCI Troponin Saga , 2012, Circulation. Cardiovascular interventions.

[94]  A. Jaffe,et al.  Why all the struggle about CK-MB and PCI? , 2012, European heart journal.

[95]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[96]  A. Sinha.  Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). , 2013 .